Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Mattel Sees FY2023 Adj EPS $1.10-$1.20 Vs $1.66 Est

2023 Guidance Mattel's full year 2023 guidance is: (in millions,   FY2023 Guidance   FY2022 except EPS and
byBenzinga Newsdesk
February 8, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

2023 Guidance

Mattel’s full year 2023 guidance is:

(in millions,   FY2023 Guidance  

FY2022

except EPS and percentages)

        
       
Net Sales   Comparable

(Constant Currency)

  

$5,435
Adjusted Gross Margin  

~ 47%

  

45.9%
Adjusted EPS  

$1.10 – $1.20

  

$1.25
Adjusted EBITDA  

$900 – $950

  

$968
Adjusted Tax Rate  

25 – 26%

  

24%
Capital Expenditures  

$175 – $200

  

$187
Free Cash Flow  

> $400

  

$256
 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

NightHawk Biosciences Announces Planned Name Change To Scorpius Holdings, Reflecting Successful Transition To A Large Molecule Biomanufacturing CDMO; In Connection With The Name Change, The Company’s Ticker Will Change To “SCPX”

By Benzinga Newsdesk
January 8, 9:55 AM
NightHawk Biosciences (NYSE:NHWK, NHWK)), an integrated contract development and manufacturing organization (CDMO), today announced that it is changing the name of the Company to Scorpius Holdings, Inc. ("Scorpius") to

NHWK